4 th European School of Dermato-Oncology: Update on Cutaneous Oncology (ESDO)

Transcription

1 4 th European School of Dermato-Oncology: Update on Cutaneous Oncology (ESDO) January 28 th 30 th, 2016 Berlin, Germany Course Directors Prof. Claus Garbe, Tuebingen, Germany Prof. Axel Hauschild, Kiel, Germany Prof. Ketty Peris, Rome, Italy Prof. Alexander Stratigos, Athens, Greece Final Program (update 03/08/2015)

2 Novotel Berlin am Tiergarten Floor Plan Ground Floor Kurland 3 Group Session Kurland 2 Group Session Plenum Kurland 1 Group Session Conference Drinks Industrial Exhibition Arkadia Urania Buffet Berlin Group Session Urbino Ceres Registration

3 Content European Association of Dermato-Oncology (EADO) 2 Target Audience 2 Educational Objectives 2 Course Organization 3 Program Overview 4 Program 6 Thursday, January 28 th, Friday, January 29 th, Saturday, January 30 th, Course Faculty 12 General Information 15 Sponsors 17 Registration Form 18

4 2 European Association of Dermato-Oncology (EADO) The EADO is a non-profit organization funded in 1999 to promote, coordinate and improve clinical and laboratory research activities in the field of skin cancer including primary and secondary prevention, early detection, clinical diagnosis and clinical and experimental research. EADO has organized many successful meetings and the upcoming ones are visible on the website ( The EADO initiates for the fourth time a course dedicated to fundamentals in skin cancer targeted to specialists and residents in the final phase of their resident program. They will benefit a comprehensive and updated course to improve their decision-making process for the management of all types and stages of skin cancer, from diagnosis, primary treatment and adjuvant treatment, to the management of locoregional disease and distant metastatic disease. Target Audience This 2,5-day educational course targets doctors who are actively involved in the treatment of skin cancer. Dermatologists or other specialists who have completed specialist training, or residents in the final year of their training program, are likely to gain the most from this course. Educational Objectives The principal aim of the course is to provide a comprehensive and detailed understanding of the decision-making process for the management of all types and stages of skin cancer. This will include diagnosis and primary treatment, management of locoregional disease and distant metastatic disease, and adjuvant treatment. This is particularly relevant given the rapid progress in our understanding of melanoma and non-melanoma skin cancer, and the development of new treatments. In particular delegates will acquire the following knowledge: 1. Strategies for diagnosis of melanoma, Merkel cell and non-melanoma skin cancer including dermoscopy and confocal laser microscopy. 2. The indications, risks and benefits and strategies for mole screening. 3. Diagnosis of skin cancer: how to break bad news. 4. The indications and methods for genetic diagnosis and genetic counseling of skin cancer patients. 5. The present AJCC staging systems and how to stage melanoma, Merkel cell and cutaneous squamous cell carcinoma, and other non-melanoma skin cancers.

5 3 6. The value of imaging and biomarkers for the detection of metastases and disease staging. 7. Adjuvant treatment of skin cancer: radiotherapy; immunotherapy; chemotherapy. 8. New systemic treatments for stage IV melanoma: targeted agents and immunotherapeutics. 9. New treatment options of advanced basal cell carcinoma. 10. New systemic treatments for advanced Merkel cell and squamous cell carcinoma. 11. The characteristics of mucosal and uveal melanomas and their treatment options. 12. Options for topical treatment of epithelial skin cancers. 13. The current classification of cutaneous lymphoma; staging and treatment options for different subtypes of cutaneous lymphoma. 14. Clinical trials in skin cancer: an update. 15. The indications and strategies for supportive treatments including best supportive care. Course Organization The course consists of plenary sessions and interactive outbreak sessions. Plenary sessions will comprise clear structured and up-to-date presentations followed by audience discussion. Voting devices will be used to respond to multiple choice questions. These questions may precede the presentation of the structured knowledge or may be presented at the end in order to test the level of knowledge the audience has gained. The main part of the course consists of 8 interactive sessions, each with no more than 25 attendants. Every participant takes part in each of these sessions which mainly comprise casebased discussion. These will be used to illustrate treatment pathways, how risk and benefit are assessed, and how management decisions are made. Claus Garbe, MD Axel Hauschild, MD Ketty Peris, MD Alexander Stratigos, MD Course Directors

6 4 Program Overview A commercial exhibition will be held on all days close to the meeting rooms. Thursday January 28 th, 2016 Group I 8:00 9:00 10:00 11:00 12:00 Group II Group III Group IV Friday January 29 th, 2016 Group I Group II Group III Group IV PLENARY SESSION 2 L. K. Sekulovic C. Höller A. Hauschild C. Garbe Break COURSE C A. Stratigos COURSE D R. Kaufmann COURSE A K. Peris COURSE B I. Zalaudek Break COURSE D R. Kaufmann COURSE A K. Peris COURSE B I. Zalaudek COURSE C A. Stratigos Lunch Saturday January 30 th, 2016 Group I Group II Group III Group IV PLENARY SESSION 4 M. Weichenthal COURSE G A. Hauschild COURSE H F. Egberts COURSE E A. Blum COURSE F C. Garbe Break COURSE H F. Egberts COURSE E A. Blum COURSE F C. Garbe COURSE G A. Hauschild Break PLENARY SESSION 5 A. Stratigos S. R. Wiegell B. Weide A. Cozzio

7 5 13:00 14:00 15:00 16:00 17:00 18:00 Welcome Session PLENARY SESSION 1 J. Grob J. Malvehy V. del Marmol G. Pellacani Break COURSE A K. Peris COURSE B I. Zalaudek COURSE C A. Stratigos COURSE D R. Kaufmann Break COURSE B I. Zalaudek COURSE C A. Stratigos COURSE D R. Kaufmann COURSE A K. Peris CUTANEOUS SIDE EFFECTS PLENARY SESSION 3 TREATMENT C. Robert A.-M. OPTIONS Forsea CLINICAL SKIN CASE DISCUSSION WITH THE EXPERTS Break COURSE E A. Blum COURSE F C. Garbe COURSE G A. Hauschild COURSE H F. Egberts Break COURSE F C. Garbe COURSE G A. Hauschild COURSE H F. Egberts COURSE E A. Blum

8 6 Program Thursday, January 28 th, :45 14:00 Welcome and course introduction Claus Garbe, Tuebingen, Germany PLENARY SESSION 1: Early detection and prevention of skin cancer Chairpersons: Ketty Peris and Hubert Pehamberger 14:00 14:20 LECTURE 1: Epidemiologic trends of melanoma and NMSC Jean Jacques Grob, Marseille, France 14:20 14:40 LECTURE 2: Can early detection of skin cancer save lives? Josep Malvehy, Barcelona, Spain 14:40 15:00 LECTURE 3: Sun protection: The dermatological key messages for the public Veronique del Marmol, Brussels, Belgium 15:00 15:20 LECTURE 4: Imaging techniques for the diagnosis of skin cancer Giovanni Pellacani, Modena, Italy 15:20 15:30 Discussion 15:30 16:00 Coffee Break 16:00 17:00 COURSE A: Recent insights in the systemic and topical treatment of basal cell carcinoma Ketty Peris, Rome, Italy 16:00 17:00 COURSE B: How to use dermoscopy in the diagnosis and treatment of NMSC? Iris Zalaudek, Graz, Austria 16:00 17:00 COURSE C: How to manage squamous cell carcinoma? Alexander Stratigos, Athens, Greece 16:00 17:00 COURSE D: Surgery and destructive methods in epithelial skin cancer Roland Kaufmann, Frankfurt, Germany 17:00 17:30 Coffee Break

9 7 17:30 18:30 COURSE B: How to use dermoscopy in the diagnosis and treatment of NMSC? Iris Zalaudek, Graz, Austria 17:30 18:30 COURSE C: How to manage squamous cell carcinoma? Alexander Stratigos, Athens, Greece 17:30 18:30 COURSE D: Surgery and destructive methods in epithelial skin cancer Roland Kaufmann, Frankfurt, Germany 17:30 18:30 COURSE A: Recent insights in the systemic and topical treatment of basal cell carcinoma Ketty Peris, Rome, Italy 18:30 Get-Together with finger food Friday, January 29 th, 2016 PLENARY SESSION 2: Melanoma diagnosis and treatment Chairpersons: Alexander Stratigos and Jean Jacques Grob 08:00 08:20 LECTURE 5: Prognostic factors of melanoma Lidija Kandolf Sekulovic, Belgrade, Serbia 08:20 08:40 LECTURE 6: Signaling pathways in melanoma: The basis of mutational screening Christoph Höller, Vienna, Austria 08:40 09:00 LECTURE 7: Adjuvant therapies for high-risk melanoma patients Axel Hauschild, Kiel, Germany 09:00 09:20 LECTURE 8: Metastatic Melanoma: Choosing the right patient for the right treatment Claus Garbe, Tuebingen, Germany 09:20 09:30 Discussion 09:30 10:00 Coffee Break

10 8 10:00 11:00 COURSE C: How to manage squamous cell carcinoma? Alexander Stratigos, Athens, Greece 10:00 11:00 COURSE D: Surgery and destructive methods in epithelial skin cancer Roland Kaufmann, Frankfurt, Germany 10:00 11:00 COURSE A: Recent insights in the systemic and topical treatment of basal cell carcinoma Ketty Peris, Rome, Italy 10:00 11:00 COURSE B: How to use dermoscopy in the diagnosis and treatment of NMSC? Iris Zalaudek, Graz, Austria 11:00 11:30 Coffee Break 11:30 12:30 COURSE D: Surgery and destructive methods in epithelial skin cancer Roland Kaufmann, Frankfurt, Germany 11:30 12:30 COURSE A: Recent insights in the systemic and topical treatment of basal cell carcinoma Ketty Peris, Rome, Italy 11:30 12:30 COURSE B: How to use dermoscopy in the diagnosis and treatment of NMSC? Iris Zalaudek, Graz, Austria 11:30 12:30 COURSE C: How to manage squamous cell carcinoma? Alexander Stratigos, Athens, Greece 12:30 13:00 Lunch PLENARY SESSION 3: Challenges and the management of skin cancer Chairpersons: Caroline Robert and Ana-Maria Forsea 13:00 13:30 LECTURE 9: Cutaneous side effects of innovative anti-neoplastic agents Caroline Robert, Paris, France 13:30-14:00 LECTURE 10: Treatment options of actinic keratosis and field cancerization Ana-Maria Forsea, Bucharest, Romania

11 9 14:00 15:00 Clinical skin cancer case discussion with the experts Claus Garbe, Tuebingen, Germany; Jean Jacques Grob, Marseille, France; Christoph Höller, Vienna, Austria; Alexander Stratigos, Athens, Greece 15:00 15:15 Coffee Break 15:15 16:15 COURSE E: How to use dermoscopy in the diagnosis and treatment of pigmented tumors? Andreas Blum, Constance, Germany 15:15 16:15 COURSE F: How to stage and follow up melanoma patients Claus Garbe, Tuebingen, Germany 15:15 16:15 COURSE G: Metastatic melanoma: An update on targeted therapies and immunotherapies Axel Hauschild, Kiel, Germany 15:15 16:15 COURSE H: Sentinel node biopsy for skin cancer: Indications, procedures and expectations Friederike Egberts, Kiel, Germany 16:15 16:30 Coffee Break 16:30 17:30 COURSE F: How to stage and follow up melanoma patients Claus Garbe, Tuebingen, Germany 16:30 17:30 COURSE G: Metastatic melanoma: An update on targeted therapies and immunotherapies Axel Hauschild, Kiel, Germany 16:30 17:30 COURSE H: Sentinel node biopsy for skin cancer: Indications, procedures and expectations Friederike Egberts, Kiel, Germany 16:30 17:30 COURSE E: How to use dermoscopy in the diagnosis and treatment of pigmented tumors? Andreas Blum, Constance, Germany

12 10 Saturday, January 30 th, 2016 PLENARY SESSION 4: Medical statistics Chairperson: Alexander Stratigos 08:00 08:30 LECTURE 11: How to read and evaluate the results of clinical trials in oncology Michael Weichenthal, Kiel, Germany 08:30 09:30 COURSE G: Metastatic melanoma: An update on targeted therapies and immunotherapies Axel Hauschild, Kiel, Germany 08:30 09:30 COURSE H: Sentinel node biopsy for skin cancer: Indications, procedures and expectations Friederike Egberts, Kiel, Germany 08:30 09:30 COURSE E: How to use dermoscopy in the diagnosis and treatment of pigmented tumors? Andreas Blum, Constance, Germany 08:30 09:30 COURSE F: How to stage and follow up melanoma patients Claus Garbe, Tuebingen, Germany 09:30 10:00 Coffee Break 10:00 11:00 COURSE H: Sentinel node biopsy for skin cancer: Indications, procedures and expectations Friederike Egberts, Kiel, Germany 10:00 11:00 COURSE E: How to use dermoscopy in the diagnosis and treatment of pigmented tumors? Andreas Blum, Constance, Germany 10:00 11:00 COURSE F: How to stage and follow up melanoma patients Claus Garbe, Tuebingen, Germany 10:00 11:00 COURSE G: Metastatic melanoma: An update on targeted therapies and immunotherapies Axel Hauschild, Kiel, Germany 11:00 11:30 Coffee Break

13 11 PLENARY SESSION 5: Update on hot topics in dermato-oncology Chairpersons: Axel Hauschild and Claus Garbe 11:30 11:50 LECTURE 12: Chemoprevention of skin cancer Alexander Stratigos, Athens, Greece 11:50 12:10 LECTURE 13: Daylight PDT for NMSC Stine Regin Wiegell, Copenhagen, Denmark 12:10 12:30 LECTURE 14: Intratumor treatment and electrochemotherapy Benjamin Weide, Tuebingen, Germany 12:30 12:50 LECTURE 15: Radiation therapy in cutaneous oncology Antonio Cozzio, Zurich, Switzerland 12:50 13:00 Discussion

14 12 Course Faculty B Andreas Blum, MD Hautarztpraxis Seestraße 3a Konstanz, Germany Phone: a.blum@derma.de F Ana Maria Forsea, MD Assistant Professor for Dermatology Carol Davila University of Medicine and Pharmacy Bucharest Bulevardul Eroii Sanitari 8 Bucharest , Romania Phone: aforsea@yahoo.com C Antonio Cozzio, MD University of Zurich Hospital Gloriastrasse Zurich, Switzerland Phone: cozzio@usz.ch E Friederike Egberts, MD University of Kiel Schittenhelmstr Kiel, Germany Phone: fegberts@dermatology.uni-kiel.de G Claus Garbe, MD Professor of Dermatology Eberhard Karls University Liebermeister Str Tuebingen, Germany Phone: claus.garbe@med.uni-tuebingen.de Jean-Jacques Grob, MD Professor of Dermatology Service de Dermatology and Cancer Research Hospital de la Timone 264 Rue St. Pierre Marseille, France Phone: jean-jacques.grob@ap-hm.fr

15 13 H Axel Hauschild, MD Professor of Dermatology University of Kiel Schittenhelmstr Kiel, Germany Phone: ahauschild@dermatology.uni-kiel.de Christoph Höller, MD Professor of Dermatology Medical University of Vienna Waehringer Gürtel Vienna, Austria Phone: christoph.hoeller@meduniwien.ac.at M Josep Malvehy, MD Director of the Melanoma Unit Hospital Clinic of Barcelona C/Villarroel Barcelona, Spain Phone: jmalvehy@clinic.ub.es Véronique del Marmol, MD Porphyria Unit Department of Clinical Chemistry Erasme Hospital - ULB Route de Lennik Brussels, Belgium Phone: v.marmol@drvdm.be K Lidija Kandolf Sekulovic, MD Military Medical Academy Crnotravska Belgrade, Serbia Phone: lkandolfsekulovic@gmail.com Roland Kaufmann, MD Professor of Dermatology, Director Clinical Center J. W. Goethe University Theodor-Stern-Kai Frankfurt am Main, Germany Phone: kaufmann@em.uni-frankfurt.de P Hubert Pehamberger, MD Professor and Chairman Medical University of Vienna Waehringer Guertel Vienna, Austria Phone: hubert.pehamberger@ meduniwien.ac.at Giovanni Pellacani, MD University of Modena and Reggio Emilia Via del Pozzo Modena, Italy Phone: pellacani.giovanni@gmail.com

16 14 Ketty Peris, MD Catholic University of Rome Largo a Gemelli, Rome, Italy Phone: ketty.peris@rm.unicatt.it R Caroline Robert, MD Head Dermatology Gustave Roussy Institute 114 rue Edouard Vaillant Villejuif, France Phone: caroline.robert@gustaveroussy.fr S Alexander Stratigos, MD University of Athens School of Medicine Andreas Sygros Hospital 5 Dragoumi Street Athens , Greece Phone: alstrat2@gmail.com Benjamin Weide, MD Eberhard Karls University Liebermeister Str Tuebingen, Germany Phone: benjamin.weide@ med.uni-tuebingen.de Stine Regin Wiegell, MD D92 Bispebjerg Hospital Bispebjerg Bakke Copenhagen NV, Denmark Phone: Stine.Regin.Wiegell@regionh.dk Z Iris Zalaudek, MD Division of Dermatology and Venerology Non-Melanoma Skin Cancer Unit Medical University of Graz Auenbruggerplatz Graz, Austria Phone: iris.zalaudek@medunigraz.at W Michael Weichenthal, MD Professor of Dermatology University of Kiel Schittenhelmstr Kiel, Germany Phone: mweichenthal@dermatology. uni-kiel.de

17 15 General Information Course Venue Novotel Berlin am Tiergarten Strasse des 17. Juni Berlin, Germany Phone: +49 (0) Course Organization MedConcept Gesellschaft für medizinische Projekte mbh Ms. Mirja Christ Friedenstraße Neuenhagen b. Berlin, Germany Phone: +49 (0) Fax: +49 (0) Accommodation MedConcept has reserved a limited number of rooms under the reference "ESDO 2016" at the Novotel Berlin am Tiergarten: Rate per standard room and night: 102,50 Euro single / 112 Euro double (breakfast included) Booking deadline: December 30, 2015 For your individual room booking, please contact the hotel directly: Phone: +49 (0) , H3649@accor.com Registration / Information Desk The registration desk is situated at the ground floor of the Novotel Berlin am Tiergarten. Opening hours Thursday, January 28 12:00 19:00 h Friday, January 29 07:30 18:00 h Saturday, January 30 08:00 14:00 h

18 16 Language and Translation The official language of the meeting will be English. Simultaneous translation will not be provided. Exhibition Opening Hours Thursday, January 28: 13:00 18:30 Friday, January 29: 07:30 17:30 Saturday, January 30: 08:00 13:30 CME Credits An application for CME accreditation will be made. Fees Registration Fee of 380 Euro (incl. VAT) covers Admission to scientific sessions Admission to exhibition Bag with course documents Welcome reception Coffee breaks and lunch Certificate of attendance A limited number of discounted admission tickets (190 Euro) are available for doctors in training and attendees coming from Eastern European countries (first come, first serve). For further information, please contact mirja.christ@medconcept.org. The participant acknowledges that he/she has no right to lodge damage claims against the organizers should the holding of the meeting be hindered or prevented by unexpected, political or economic events or generally by force, or should the non-appearance of speakers or other reasons need program changes. With registration, the participant accepts this proviso. Cancellation Policy Cancellations must be received in writing by December 17, No refunds will be granted after that date. A processing fee of 30 Euro will be deducted from each cancelled registration. Substitutions are possible. To substitute a registration please send an including the name of the original registrant and the name of the person substituting to mirja.christ@medconcept.org. The participant acknowledges that he/she has no right to lodge damage claims against the organizers should the holding of the meeting be hindered or prevented by unexpected, political or economic events or generally by force, or should the non-appearance of speakers or other reasons need program changes. With registration, the participant accepts this proviso.

19 17 Sponsors GOLD SPONSORS Euro Gold Sponsorship FURTHER SPONSORS Almirall (5.000 Euro Sponsorship) Derma Medical Systems

20 Registration Form Fourth European School of Dermato-Oncology Berlin, Germany, January 28th 30th, 2016 First Name: Last Name: Professional Title: Degree: MD PhD RN PA-C Gender: Male Female Speciality: Institution: Address: City: Zip Code: Country: Phone: Fax: Fees Registration Fee of 380,00 Euro (incl. VAT) covers Admission to scientific sessions Admission to exhibition Bag with course documents Welcome reception Coffee breaks and lunch Certificate of Attendance Payment Method Bank Transfer: Registration can only be confirmed upon receipt of full payment. Credit Card: MasterCard Visa American Express Credit Card Number: Expiration Date: Security Code CCV: (MC/Visa 3 digits on back, AMEX 4 digits on front) Cardholder Name: Signature: An invoice will be send by to the given address. If the invoice address is different from the address given above, please send an including the name of the registrant and the full invoice address to mirja.christ@medconcept.org. By completing the registration form, the participant accepts the cancellation policy as stated in the course program. To Register Mail registration form to: MedConcept GmbH, Friedenstraße Neuenhagen bei Berlin, Germany Fax registration form to: +49 (0) Register online:

21 SAVE THE DATE Early Bird Registration until April 5, 2016 Save the Date June 30 th July 1 st, 2016 Munich, Germany 6 th European Post-Chicago Melanoma/Skin Cancer Meeting Congress Presidents Axel Hauschild, Kiel, Germany Claus Garbe, Tuebingen, Germany Cover picture: Harald Hoyer Layout: MediaService GmbH Druck und Kommunikation